This study aims to identify broad-spectrum antiviral drugs with potential treating for feline infectious peritonitis and virulent, systemic feline calicivirus infection in cats.

This study examines the potential of a novel therapy for feline oral squamous cell carcinoma, which is the most common oral cancer in cats.

This study will sequence the entire genome of a bovine strain and a feline strain of Tritrichomonas foetus to determine whether these are distinct species and to help develop more effective therapies.

This study investigates the safety and efficacy of long-term use of the topical antiviral drug cidofovir in cats with chronic feline herpesvirus infection.

This study will establish the MK-467 dose needed to counteract the effect of dexmedetomidine on heart rate and will characterize how the drug's concentration changes in blood over time.

This project will develop methods for detecting infection with a newly discovered feline herpesvirus and will determine whether this infection is associated with common feline cancers.

This study investigates novel, targeted therapies for the treatment of feline Tritrichomonas foetus infection.

This study investigates ways to improve early detection of cardiomyopathy (heart disease) by primary care veterinarians in pet cats.

Researchers will study metabolic irregularities associated with osteosarcoma that may contribute to disease progression, chemotherapy resistance and cancer spread.

Researchers will look at how lesions or nodules form in dogs with mitral valve disease and use this new information to look for new targeted therapies for this common canine heart disease.